Efficacy and Safety of Saussurea Involucrata Liquid Tonic in Patient With Postpartum Rheumatism
NCT06430307 · Status: NOT_YET_RECRUITING · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 128
Last updated 2024-05-28
Summary
This study is a multi-center, randomized, double-blinded, controlled trial with two parallel arms. The study aims to evaluate the efficacy and safety of Involucrata Liquid Tonic in patients with Postpartum Rheumatism.
Conditions
- Postpartum Rheumatism
Interventions
- DRUG
-
Saussurea Involucrata Liquid Tonic
This product is a single preparation of Saussurea Involucrata Liquid Tonic. It is used for rheumatoid arthritis, rheumatoid arthritis and dysmenorrhea caused by insufficient kidney yang and cold-damp stasis.
Sponsors & Collaborators
-
Quan Jiang
lead OTHER
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- QUADRUPLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Max Age
- 50 Years
- Sex
- FEMALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2024-07-31
- Primary Completion
- 2025-07-31
- Completion
- 2025-12-31
More Related Trials
-
Assessment of the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Multiple Subcutaneous Injections of GenSci120 in Healthy Adult Participants in China.
NCT07040930 ·Status: RECRUITING ·Phase: PHASE1
-
An Efficacy and Safety Study of CNTO 148 Subcutaneous Injection Compared With Placebo in Patients With Active Rheumatoid Arthritis
NCT00207714 ·Status: COMPLETED ·Phase: PHASE2
-
A Study of Effectiveness and Safety of CNTO 136 in Patients With Active Rheumatoid Arthritis Despite Methotrexate Therapy
NCT00718718 ·Status: COMPLETED ·Phase: PHASE2
-
Ultrasound Treatment of Rheumatoid Arthritis
NCT03690466 ·Status: COMPLETED ·Phase: NA
-
Ultrasound Neuroimmune Modulation in Adults With Rheumatoid Arthritis
NCT07293871 ·Status: RECRUITING ·Phase: PHASE2
-
Efficacy and Safety of CDP870 Versus Placebo in the Treatment of the Signs and Symptoms of Rheumatoid Arthritis
NCT00548834 ·Status: COMPLETED ·Phase: PHASE3
-
Study To Evaluate The Safety And Efficacy Of ILV-094 In Subjects With Rheumatoid Arthritis
NCT00883896 ·Status: COMPLETED ·Phase: PHASE2
-
A Study of the Safety and Efficacy of Golimumab in Subjects With Rheumatoid Arthritis That Are Methotrexate-naive
NCT00264537 ·Status: COMPLETED ·Phase: PHASE3
-
A Study of LNK01001 Capsule in Subjects With Active Rheumatoid Arthritis (COURAGE-RA)
NCT06276998 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
Efficacy and Safety of Colquhounia Root Tablet in Patients With Rheumatoid Arthritis
NCT05393050 ·Status: UNKNOWN ·Phase: PHASE4
-
Efficacy and Safety of Tocilizumab in Combination With DMARDs in Patients With Moderate to Severe Rheumatoid Arthritis
NCT01211834 ·Status: COMPLETED ·Phase: PHASE3
-
Modified Zhiwang Decoction Combined With Methotrexate in the Treatment of Early Rheumatoid Arthritis
NCT05508815 ·Status: UNKNOWN ·Phase: EARLY_PHASE1
-
Effect of Subcutaneous Polyvidone Collagen Treatment on Hand Recovery in Adult Rheumatoid Arthritis.
NCT06656169 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Comparison Of 6 CP-690,550 Doses Vs.Placebo, Each Combined With Methotrexate, For The Treatment Of Rheumatoid Arthritis
NCT00413660 ·Status: COMPLETED ·Phase: PHASE2
-
A Phase 3 Study Comparing 2 Doses of CP-690,550 vs. Placebo for Treatment of Rheumatoid Arthritis
NCT00814307 ·Status: COMPLETED ·Phase: PHASE3
-
Safety and Efficacy Study of Adalimumab in Adult Chinese Rheumatoid Arthritis Subjects Treated With Methotrexate
NCT00538902 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
A Multi-center Study a Single IV Infusion of Allogeneic MPCs in Patients With Rheumatoid Arthritis and Incomplete Response to at Least One TNFα Inhibitor
NCT01851070 ·Status: COMPLETED ·Phase: PHASE2
-
Treatment of Pregnancy RA
NCT04569890 ·Status: UNKNOWN ·Phase: NA
-
Subcuteous Methotrexate in Rheumatoid Arthritis
NCT07094880 ·Status: COMPLETED ·Phase: PHASE4
-
A Study of GNC-038 Tetra-specific Antibody Injection in Patients With Rheumatoid Arthritis
NCT06857227 ·Status: RECRUITING ·Phase: PHASE1
-
Assess Safety, Tolerability, Pharmacokinetics and Clinical Activity of AMP-110 in Subjects With Rheumatoid Arthritis
NCT02277574 ·Status: COMPLETED ·Phase: PHASE1
-
A Study Comparing LBEC0101 to Enbrel® in Subjects With Active Rheumatoid Arthritis Despite Methotrexate Therapy
NCT02357069 ·Status: UNKNOWN ·Phase: PHASE3
-
Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single Dose CFZ533 in Rheumatoid Arthritis Patients
NCT02089087 ·Status: COMPLETED ·Phase: PHASE1
-
An Efficacy and Safety Study of Subcutaneous Tocilizumab in Combination With Methotrexate (MTX) and as Monotherapy Versus MTX in Participants With Moderate to Severe Rheumatoid Arthritis With Inadequate Response to Current Disease-Modifying Antirheumatic Drug (DMARD) Therapy
NCT03155347 ·Status: COMPLETED ·Phase: PHASE3
-
Study of Adalimumab Administered as Subcutaneous Injections in Adult Chinese Rheumatoid Arthritis Subjects Treated With Methotrexate
NCT00647920 ·Status: COMPLETED ·Phase: PHASE3